Condition
Urine Marking
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06220903Not ApplicableCompleted
The Effect of Complex Decongestive Therapy in Patients With Lymphedema
NCT03998371Unknown
Application of UCAD for Diagnosing Urothelial Carcinoma.
NCT03563443Unknown
Genomic Imprinting Testing for Diagnosis of Bladder Cancer
NCT02348944Completed
Biological Variability in Cartilage Specific Biomarkers in Healthy Volunteers.
Showing all 4 trials